Unraveling the Molecular Mechanisms of Hair and Nail Genodermatoses

    November 2001 in “ Archives of Dermatology
    Alexander J. Stratigos, Howard P. Baden
    Image of study
    TLDR Genetic discoveries are key for understanding, diagnosing, and treating inherited hair and nail disorders.
    The document from 2001 reviewed the progress in understanding the molecular mechanisms of inherited hair and nail diseases, highlighting the identification of genes responsible for these disorders. It discussed ectodermal dysplasias, particularly EDA and HED, which are caused by mutations in the EDA and GJB6 genes, respectively. Monilethrix was attributed to mutations in hair keratins hHb6 and hHb1. The document also covered Netherton syndrome (NS), Trichothiodystrophy (TTD), Menkes kinky hair syndrome, Trichorrhexis nodosa, congenital atrichia with papules, the human nude phenotype, and pachyonychia congenita (PC), all linked to specific gene mutations. It emphasized the importance of these discoveries for understanding the pathogenesis of these conditions and their implications for diagnosis and treatment. Additionally, it mentioned Pachyonychia Congenita types 1 and 2, caused by mutations in the K16 and K17 genes, and Nail-Patella Syndrome, caused by mutations in the LMX1B gene. The document concluded that these genetic insights are crucial for understanding the biology of epidermal appendages and anticipated future therapeutic strategies, including gene therapy.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    1 / 1 results

      community Verteporfin and Microneedling

      in Treatments 5 months ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.

    Similar Research

    5 / 1000+ results